EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes

Katherine P Lee, Benjamin Epstein, Camille M Lake, Andrew L Snow

Frontiers in Cell Death · 2023

DOI: 10.3389/fceld.2023.1281137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell Death, 2023. Verfasst von Katherine P Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For effective adaptive immunity, T lymphocytes must rapidly expand and contract in an antigen-specific manner to effectively control invading pathogens and preserve immunological memory, without sustaining excessive collateral damage to host tissues. Starting from initial antigen encounter, carefully calibrated programmed cell death pathways are critical for maintaining homeostasis over distinct phases of the T cell response. Restimulation-induced cell death (RICD), a self-regulatory apoptosis pathway triggered by re-engagement of the T cell receptor (TCR), is particularly important for constraining effector T cell expansion to preclude overt immunopathology; indeed, genetic disorders affecting key molecules involved in RICD execution can manifest in excessive lymphoproliferation, malignancy, and autoimmunity. Herein we review our current knowledge of how RICD sensitivity is ultimately regulated over the course of an immune response, including recent revelations on molecules that tune RICD by enforcing resistance or promoting susceptibility in expanding versus mature effector T cells, respectively. Detailed dissection of the molecular and temporal control of RICD also illuminates novel therapeutic strategies for correcting abnormal T cell responses noted in various immune disorders by ultimately tuning RICD sensitivity.

Schlagwörter

Stichwörter der Autor:innen

ALPSCWIDRICDT cell receptorXLP-1apoptosismetabolism

Autor:innen und Institutionen

  • Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Lee, K. P., Epstein, B., Lake, C. M., & Snow, A. L. (2023). Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes. Frontiers in Cell Death. https://doi.org/10.3389/fceld.2023.1281137

Vancouver

Lee KP, Epstein B, Lake CM, Snow AL. Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes. Frontiers in Cell Death. 2023. doi:10.3389/fceld.2023.1281137

BibTeX
@article{Lee2023,
  author = {Lee, Katherine P and Epstein, Benjamin and Lake, Camille M and Snow, Andrew L},
  title = {Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes},
  journal = {Frontiers in Cell Death},
  year = {2023},
  doi = {10.3389/fceld.2023.1281137}
}
Kostenlos starten →